dc.contributor.author | Ћорац, Александар | |
dc.contributor.author | Мијовић, Милица | |
dc.date.accessioned | 2022-09-19T09:12:36Z | |
dc.date.available | 2022-09-19T09:12:36Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Индустрија производње олова и цинка, последице по становништво и уређење и заштита екосистема TR37016 | en_US |
dc.identifier.uri | https://platon.pr.ac.rs/handle/123456789/456 | |
dc.description.abstract | Background/Aim. Neuroendocrine (NE) cells are one of
the epithelial populations in the prostate. It is well-known
that the focal neuroendocrine differentiation (FNED) in
prostate cancer (PC) is an aggressive subtype that most
commonly evolves from preexisting PC which does not respond to hormone therapy (androgen independed PC). The
incidence and clinical importance of FNED in PC is not
clearly understood because of conflicting results in the studies, and evaluation of FNED is not routinely performed in
clinical practice. The aim of the present study is to determine the importance of FNED presence in the examined
prostate changes with special reference to the relationship
of FNED degree in PC with some parameters of predictive
value [Gleason score, preoperative serum total prostata specific antigen (PSA) value, tumor volume and tumor stage].
Methods. The study included the biopsy material from 100
untreated consecutive prostate pathological changes: 70 PC,
20 prostatic intraepithelial neoplasia (PIN) and 10 benign
prostatic hyperplasia (BPH). The patients with PIN and
BPH were the control groups. A block containing part of
the main bulk of pathological change was chosen as representative based on hematoxylin-eosin appearance, and a section of this block was immunohistochemically stained for
the tissue PSA (to mark prostatic secretory cells) and chromogranin A, serotonin and synaptophysin (to mark NE
cells). Results. We found a very pronounced degree of
FNED differentiation in 16 (22.9%) PC. Ten (62.5%) of
them had Gleason score ≥ 7, the average serum PSA level
was 32.62 ± 30.80 ng/mL, average tumor volume was
43.18 ± 31.45 mL and 6 (37.5%) of this PC were detected in
D clinical stage with distant hematogenous metastases. The
FNED is negatively correlated with the serum PSA level,
Gleason score and clinical stage positively correlated with
the tumor volume, but without statistically significant differences. Conclusion. The FNED has no significant role in
the prognosis of PC. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Vojnosanitetski Pregled, MILITARY MEDICAL ACAD-INI | en_US |
dc.title | Correlation of focal neuroendocrine differentiation in prostate cancer with parameters of predictive value | en_US |
dc.title.alternative | Vojnosanitetski Pregled, MILITARY MEDICAL ACAD-INI | en_US |
dc.type | clanak-u-casopisu | en_US |
dc.description.version | publishedVersion | en_US |
dc.citation.spage | 76(11 | |
dc.subject.keywords | prostatic neoplasms; neuroendocrinology; prostatespecific antigen; risk factors; neoplasm staging; prognosis. | en_US |
dc.type.mCategory | M23 | en_US |
dc.type.mCategory | openAccess | en_US |
dc.type.mCategory | M23 | en_US |
dc.type.mCategory | openAccess | en_US |